Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.

Affiliation

Page MJ(1), McKenzie JE(2), Bossuyt PM(3), Boutron I(4), Hoffmann TC(5), Mulrow CD(6), Shamseer L(7), Tetzlaff JM(8), Moher D(9).
Author information:
(1)School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Electronic address: [Email]
(2)School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
(3)Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands.
(4)Université de Paris, Centre of Epidemiology and Statistics
(CRESS), Inserm, F 75004, Paris, France.
(5)Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
(6)University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
(7)School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
(8)Evidence Partners, Ottawa, Canada.
(9)School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa.

Abstract

OBJECTIVES: To describe the processes used to update the PRISMA 2009 statement for reporting systematic reviews, present results of a survey conducted to inform the update, summarize decisions made at the PRISMA update meeting, and describe and justify changes made to the guideline. METHODS: We reviewed 60 documents with reporting guidance for systematic reviews to generate suggested modifications to the PRISMA 2009 statement. We invited 220 systematic review methodologists and journal editors to complete a survey about the suggested modifications. The results of these projects were discussed at a 21-member in-person meeting. Following the meeting, we drafted the PRISMA 2020 statement and refined it based on feedback from co-authors and a convenience sample of 15 systematic reviewers. RESULTS: The review of 60 documents revealed that all topics addressed by the PRISMA 2009 statement could be modified. Of the 110 survey respondents, more than 66% recommended keeping six of the original checklist items as they were and modifying 15 of them using wording suggested by us. Attendees at the in-person meeting supported the revised wording for several items but suggested rewording for most to enhance clarity, and further refinements were made over six drafts of the guideline. CONCLUSIONS: The PRISMA 2020 statement consists of updated reporting guidance for systematic reviews. We hope that providing this detailed description of the development process will enhance the acceptance and uptake of the guideline and assist those developing and updating future reporting guidelines.